Gene Techno Science Co Ltd (4584):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gene Techno Science Co Ltd (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8032
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-004, for oncology; GND-001 for immunological disease and oncology; and GND-007 for immunological disease. GTS also develops biosimilar products including GBS-010 for oncology, GBS-011 for renal disease, and GBS-008 for infectious disease. The company’s primary product granulocyte colony stimulating factor (G-CSF) promotes the differentiation and growth of neutrophils one of the white blood cells and increases neutrophils’ functions. It conducts research and development of new biopharmaceuticals collaborating with universities and research institutions. The company has its operations in Osaka, Sapporo, and Tokyo, Japan. GTS is headquartered in Sapporo, Japan.

Gene Techno Science Co Ltd (4584) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gene Techno Science, AIN Holdings, North Pacific Bank Form Joint Venture 10
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Gene Techno Science Enters into Agreement with Changchun Changsheng Life Sciences 14
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 15
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 16
Gene Techno Science Enters Into Co-Development Agreement With Fuso Pharma Industries 17
Equity Offering 18
Gene Techno Science Raises USD2.7 Million in Private Placement of Shares 18
Gene Techno Science Raises USD4.3 Million in Private Placement of Shares 19
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 20
Gene Techno Science Completes IPO Of Shares 21
Debt Offering 22
Gene Techno Science Completes Private Placement Of Bonds Due 2018 For US$2 Million 22
Acquisition 23
NanoCarrier to Acquire 5.23% Stake in Gene Techno Science for USD11.4 Million 23
Gene Techno Science Co Ltd – Key Competitors 24
Gene Techno Science Co Ltd – Key Employees 25
Gene Techno Science Co Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gene Techno Science Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gene Techno Science, AIN Holdings, North Pacific Bank Form Joint Venture 10
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Gene Techno Science Enters into Agreement with Changchun Changsheng Life Sciences 14
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 15
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 16
Gene Techno Science Enters Into Co-Development Agreement With Fuso Pharma Industries 17
Gene Techno Science Raises USD2.7 Million in Private Placement of Shares 18
Gene Techno Science Raises USD4.3 Million in Private Placement of Shares 19
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 20
Gene Techno Science Completes IPO Of Shares 21
Gene Techno Science Completes Private Placement Of Bonds Due 2018 For US$2 Million 22
NanoCarrier to Acquire 5.23% Stake in Gene Techno Science for USD11.4 Million 23
Gene Techno Science Co Ltd, Key Competitors 24
Gene Techno Science Co Ltd, Key Employees 25
Gene Techno Science Co Ltd, Other Locations 26

List of Figures
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gene Techno Science Co Ltd (4584):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crescent Point Energy Corp (CPG):企業の財務・戦略的SWOT分析
    Crescent Point Energy Corp (CPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Groupe SMCP S.A.S.:企業の戦略的SWOT分析
    Groupe SMCP S.A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ASM International NV (ASM):企業の財務・戦略的SWOT分析
    ASM International NV (ASM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • PepsiCo Inc:戦略・SWOT・企業財務分析
    PepsiCo Inc - Strategy, SWOT and Corporate Finance Report Summary PepsiCo Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. …
  • Metsa Board Corporation:企業のM&A・事業提携・投資動向
    Metsa Board Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metsa Board Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Skinvisible Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc, is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company provides products su …
  • Magnit:企業の戦略・SWOT・財務分析
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • PharmaCell BV-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCell BV (PharmaCell) is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine. The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scale-up, manufacturing of adva …
  • Cosan S.A. Industria e Comercio (CSAN3):企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoim …
  • Prosafe SE (PRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Prosafe SE (Prosafe) is a provider of semi-submersible accommodation support and service vessels to the oil and gas industry. The company’s operations are related to maintenance and modification of installations on fields already in production, hook-up and commissioning of new fields, tie-ba …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Competitive Power Ventures Inc:企業の戦略的SWOT分析
    Competitive Power Ventures Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Severn Glocon Group Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Severn Glocon Group Plc (Severn Glocon), formerly Sageshire Ltd is a designer and manufacturer of engineered valve products. The company offers control, choke, and subsea valves; small bore subsea valves and actuators; filters and dryers; low-friction valve actuators, engineered valves, meta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆